Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

PTC Therapeutics

Request full access

A science-led, patient-centered biopharmaceutical company focused on discovering, developing and commercializing medicine for patients with rare disease

South Plainfield, United StatesFounded 1998Biotech & Life Sciences

At a glance

Status
Listed
Listing
IPO 2013

PTC Therapeutics in the South Plainfield ecosystem

Live from Dealroom

The PTC Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later21 investors entered at this stage

  • HealthCap
  • Longwood Fund
  • HBM BioVentures
  • Jennison Associates
  • HBM Healthcare Investments
  • Novo Holdings
  • CDIB Capital Group
  • Rutgers university
  • Adage Capital
  • Credit Suisse First Boston
  • Delphi Ventures
  • Cercano Management
  • Manulife Financial
  • Bay City Capital
  • Celgene
  • Credit Suisse
  • New Medical Technologies
  • The Column Group
  • Amgen Ventures
  • Brookside Capital
  • CDI Bioscience
Employees mapped 1,150 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 10 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 8 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$168M

118 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See PTC Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.